@jepcastel

Strong control over multiple endpoints: are we adding value to the assessment of medicines?

, and . Pharmaceutical statistics, 12 (4): 189-91 (May 2013)7342<m:linebreak></m:linebreak>JID: 101201192; 2013/01/12 received; 2013/02/13 revised; 2013/04/11 accepted; aheadofprint;<m:linebreak></m:linebreak>Comparacions múltiples.
DOI: 10.1002/pst.1574

Links and resources

Tags